Evidence map›Paper›PMID 39474461›Full record

ArticleFrontiers in neuroscience2024

Positron emission tomography neuroimaging of [

Alexander K Converse, Maryann N Krasko, Denis Michael Rudisch, Charlie Lenell Lunaris, Alex F Nisbet, Maxim S Slesarev, John C Szot, Andrew G Hoerst, Glen E Leverson, Catherine L Gallagher and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Positron Emission Tomography (PET) Neuroimaging of theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexander K ConverseWaisman Center, University of Wisconsin-Madison, Madison, WI, United States.
Maryann N KraskoDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Denis Michael RudischDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Charlie Lenell LunarisDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Alex F NisbetDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Maxim S SlesarevWaisman Center, University of Wisconsin-Madison, Madison, WI, United States.
John C SzotDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Andrew G HoerstDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Glen E LeversonDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.
Catherine L GallagherDepartment of Neurology, University of Wisconsin-Madison, Madison, WI, United States.
Michelle R CiucciDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, WI, United States.

Funding

Waisman Center Intellectual and Developmental Disabilities Research CenterP50HD105353 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI Brittany Gail Travers · 2021 to 2026
$8.5M
Preclinical trial for dysarthria treatment in Parkinson diseaseR01DC018584 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI CIUCCI, MICHELLE RENEE · 2021 to 2025
$3.3M
Vocal dysfunction and vagally mediated brainstem pathology in prodromal Parkinson diseaseF31DC022161 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI KRASKO, MARYANN N · 2024 to 2024
$43k
NICHD NIH HHS P50 HD105353NIDCD NIH HHS F31 DC022161NIDCD NIH HHS R01 DC018584
6 · The paper itself

Abstract

Introduction: Parkinson disease (PD) is a neurodegenerative condition affecting multiple sensorimotor and cognitive systems. The Methods: Results: Relative glucose metabolism was significantly different in Conclusion: FDG PET reveals abnormalities in relative regional brain glucose metabolism in

Indexed as

[18F]fluorodeoxyglucoseCylinder TestFive-Choice Serial Reaction Time TaskParkinson diseasePink1−/− rat modelpositron emission tomographyTapered Balance Beamultrasonic vocalizations

Identifiers

PMID39474461
PMCPMC11520326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.